Welcome to our dedicated page for Syra Health news (Ticker: SYRA), a resource for investors and traders seeking the latest updates and insights on Syra Health stock.
Syra Health Corp. (SYRA) is a leading healthcare technology company focused on improving population health outcomes through innovative behavioral health solutions and workforce development programs. This page provides official updates and press releases directly from Syra Health, offering stakeholders timely insights into strategic initiatives.
Investors and healthcare professionals will find comprehensive coverage of SYRA's latest developments, including new contract awards, digital health product launches, and partnerships with government agencies. The curated news collection serves as a reliable resource for tracking the company's progress in mental health innovation and preventative care technologies.
All content is sourced from verified corporate communications, ensuring accuracy across updates about population health management systems, healthcare training advancements, and AI-driven behavioral health tools. Regular visitors can monitor SYRA's growing influence in addressing critical challenges like workforce shortages and health equity gaps.
Bookmark this page for streamlined access to Syra Health's evolving role in shaping healthcare delivery through science-driven solutions and measurable community impact.
Syra Health Corp. announced a strong revenue growth of 47% in the first quarter of 2024. The company reported revenue of $1.7 million, a significant increase from $1.2 million in the same period last year. Syra Health anticipates a full-year revenue of $9 to $11 million for 2024, marking a substantial growth compared to 2023. The company highlighted operational achievements, including securing multiple contracts and expanding business units. Dr. Deepika Vuppalanchi, CEO of Syra Health, expressed confidence in the company's growth trajectory and revenue guidance. However, the company reported a decrease in gross profit margin and a net loss of $(1.4 million) for the first quarter of 2024.
Syra Health Corp. (NASDAQ: SYRA) has been awarded a contract to conduct a comprehensive needs assessment for Middlesex County, NJ, and develop a Community Health Improvement Plan. This project aims to identify health, behavioral health, and community service needs of residents, outlining priorities for improving health outcomes.
Syra Health Corp. presented Overdose Lifeline with the inaugural Syra Health Mental and Behavioral Health Solutions Award. The award recognizes the advocacy group's efforts in combating the opioid crisis and promoting mental health awareness. Syra Health aims to improve healthcare through innovative technology solutions and plans to continue hosting the award annually.
Syra Health Corp. will discuss its first quarter 2024 financial results on May 9, 2024, before the market opens. The conference call will be held at 9:00 AM ET on the same day for interested parties to review the results. Access to the call and webcast is available on the company's website. Investors can submit questions via email for the call.
FAQ
What is the current stock price of Syra Health (SYRA)?
What is the market cap of Syra Health (SYRA)?
